Suchergebnisse - "TACHAS GEORGE"

PubPharm (58)

1

BIOMARKERS AND USES THEREOF IN DIAGNOSIS AND TREATMENT OF NEUROLOGICAL POST ACUTE SEQUELAE OF COVID 19 (NPASC)

enthalten in: Europäisches Patentamt | 2024

von TACHAS GEORGE

2

BIOMARKERS AND USES THEREOF IN DIAGNOSIS AND TREATMENT OF NEUROLOGICAL POST ACUTE SEQUELAE OF COVID 19 (NPASC)

enthalten in: Europäisches Patentamt | 2024

von TACHAS GEORGE

3

Methods for treating multiple sclerosis using antisense oligonucleotides

enthalten in: Europäisches Patentamt | 2024

von TACHAS GEORGE

4

A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice

enthalten in: PloS one | 2024

von Woodcock, I. | Tachas, G. | Desem, N. | +18

5

Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection

enthalten in: Brain, behavior, and immunity | 2023

von Hanson, B. | Visvabharathy, L. | Orban, Z. | +9

6

METHODS FOR TREATING MUSCULAR DYSTROPHY USING INHIBITORY OLIGONUCLEOTIDES TO CD49D

enthalten in: Europäisches Patentamt | 2023

von TACHAS GEORGE

7

Oligo antisentido para su uso en el tratamiento de la leucemia mieloide aguda

enthalten in: Europäisches Patentamt | 2023

von TACHAS GEORGE | KIM YONG-MI

8

METHODS AND KITS THEREFOR

enthalten in: Europäisches Patentamt | 2023

von TACHAS GEORGE

9

METHOD FOR REDUCING CIRCULATING LEUKOCYTES IN A HUMAN SUBJECT

enthalten in: Europäisches Patentamt | 2023

von TACHAS GEORGE

10

Corrigendum : Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein

enthalten in: Frontiers in immunology | 2023

von Visvabharathy, L. | Hanson, B. | Orban, Z. | +9

ErratumFor: Front Immunol. 2023 May 29;14:1155770. - PMID 37313412

1
2
3
4
5
6
Nächster »
[6]